Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for CSTL

Stock NameCastle Biosciences Inc
TickerCSTL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS14843C1053

Show aggregate CSTL holdings

News associated with CSTL

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Recommendation of “Moderate Buy” by Brokerages
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine brokerages that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month price objective among brokerages […] - 2025-09-04 02:46:48
Mackenzie Financial Corp Has $550,000 Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)
Mackenzie Financial Corp boosted its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 30.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,460 shares of the company’s stock after buying an additional 6,440 shares during the period. Mackenzie Financial Corp […] - 2025-08-08 05:02:56
Castle Biosciences (NASDAQ:CSTL) Shares Gap Up Following Earnings Beat
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares gapped up prior to trading on Tuesday following a better than expected earnings announcement. The stock had previously closed at $15.32, but opened at $19.85. Castle Biosciences shares last traded at $21.06, with a volume of 249,752 shares traded. The company reported $0.15 EPS for the […] - 2025-08-07 02:13:00
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in Castle Biosciences, Inc. (NASDAQ:CSTL)
Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 11,753 shares of the company’s stock, valued at approximately $235,000. A number of other institutional investors have also added to or reduced their stakes in CSTL. Allianz Asset Management […] - 2025-08-05 04:38:48
Envestnet Asset Management Inc. Has $1.40 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL)
Envestnet Asset Management Inc. decreased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 4.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 69,771 shares of the company’s stock after selling 3,573 shares during the quarter. Envestnet Asset Management Inc. owned […] - 2025-08-01 05:01:11
GSA Capital Partners LLP Sells 3,658 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
GSA Capital Partners LLP decreased its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 67,143 shares of the company’s stock after selling 3,658 shares during the period. GSA Capital Partners LLP owned about 0.23% of […] - 2025-07-31 05:32:57
Stephens Inc. AR Sells 800 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Stephens Inc. AR cut its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,639 shares of the company’s stock after selling 800 shares during the period. Stephens Inc. AR’s holdings in Castle Biosciences were worth $273,000 as of its most recent filing […] - 2025-07-21 05:10:45
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $37.00
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given an average rating of “Buy” by the eight brokerages that are currently covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock in the […] - 2025-06-24 02:16:45
Two Sigma Advisers LP Takes Position in Castle Biosciences, Inc. (NASDAQ:CSTL)
Two Sigma Advisers LP acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund acquired 11,500 shares of the company’s stock, valued at approximately $306,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Covestor Ltd acquired […] - 2025-06-06 05:12:48
Squarepoint Ops LLC Trims Position in Castle Biosciences, Inc. (NASDAQ:CSTL)
Squarepoint Ops LLC trimmed its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 51.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 17,317 shares of the company’s stock after selling 18,142 shares during the period. Squarepoint Ops LLC’s holdings in Castle Biosciences were […] - 2025-06-05 05:04:48
Public Employees Retirement System of Ohio Lowers Stake in Castle Biosciences, Inc. (NASDAQ:CSTL)
Public Employees Retirement System of Ohio lowered its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 16.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 74,132 shares of the company’s stock after selling 14,776 shares […] - 2025-06-02 05:34:54
Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL)
Man Group plc bought a new stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 13,302 shares of the company’s stock, valued at approximately $354,000. Several other hedge funds have also recently made changes […] - 2025-05-27 05:34:50
Nuveen Asset Management LLC Has $12.41 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL)
Nuveen Asset Management LLC lowered its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 14.2% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 465,526 shares of the company’s stock after selling 77,067 shares during the period. Nuveen Asset Management LLC’s holdings in […] - 2025-05-27 04:44:54
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Average Rating of “Buy” from Analysts
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have received an average recommendation of “Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have updated their coverage on […] - 2025-05-27 02:32:56
D. E. Shaw & Co. Inc. Makes New $2.41 Million Investment in Castle Biosciences, Inc. (NASDAQ:CSTL)
D. E. Shaw & Co. Inc. acquired a new position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 90,563 shares of the company’s stock, valued at approximately $2,414,000. Other institutional investors also recently bought and sold shares of the company. JPMorgan Chase & […] - 2025-05-21 05:44:54
Ameriprise Financial Inc. Sells 33,193 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Ameriprise Financial Inc. trimmed its holdings in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 316,036 shares of the company’s stock after selling 33,193 shares during the quarter. Ameriprise Financial Inc.’s […] - 2025-05-21 04:28:51
Castle Biosciences, Inc. (NASDAQ:CSTL) Stake Cut by Jane Street Group LLC
Jane Street Group LLC cut its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 59.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 59,383 shares of the company’s stock after selling 86,001 shares during the quarter. Jane Street Group […] - 2025-05-19 04:56:50
Schonfeld Strategic Advisors LLC Sells 40,700 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Schonfeld Strategic Advisors LLC cut its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 72.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 15,300 shares of the company’s stock after selling 40,700 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Castle Biosciences were worth $408,000 as of […] - 2025-05-12 05:42:51
Wells Fargo & Company MN Buys 3,460 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Wells Fargo & Company MN lifted its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 29.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,375 shares of the company’s stock after acquiring an additional 3,460 shares during the period. Wells […] - 2025-05-05 04:23:03
CANADA LIFE ASSURANCE Co Sells 2,506 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
CANADA LIFE ASSURANCE Co trimmed its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 19.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,713 shares of the company’s stock after selling 2,506 shares during the quarter. CANADA LIFE ASSURANCE Co’s holdings […] - 2025-05-01 05:40:55
LPL Financial LLC Sells 3,421 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
LPL Financial LLC decreased its position in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 12.9% in the 4th quarter, Holdings Channel reports. The fund owned 23,043 shares of the company’s stock after selling 3,421 shares during the quarter. LPL Financial LLC’s holdings in Castle Biosciences were worth $614,000 as of its most […] - 2025-04-24 04:16:59
ExodusPoint Capital Management LP Sells 32,779 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
ExodusPoint Capital Management LP cut its position in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 74.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 11,484 shares of the company’s stock after selling 32,779 shares during the period. ExodusPoint Capital Management LP’s holdings in Castle Biosciences were […] - 2025-04-14 05:58:59
Corebridge Financial Inc. Sells 972 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL)
Corebridge Financial Inc. lessened its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 7.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,860 shares of the company’s stock after selling 972 shares during the quarter. Corebridge Financial Inc.’s holdings in Castle Biosciences […] - 2025-04-11 04:54:48
Brokerages Set Castle Biosciences, Inc. (NASDAQ:CSTL) PT at $38.75
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) has been given a consensus rating of “Buy” by the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock […] - 2025-04-10 03:07:07
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Sei Investments Co.
Sei Investments Co. lifted its stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 9.6% during the 4th quarter, HoldingsChannel reports. The fund owned 41,491 shares of the company’s stock after acquiring an additional 3,617 shares during the period. Sei Investments Co.’s holdings in Castle Biosciences were worth $1,106,000 at the end […] - 2025-04-08 04:31:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Bought by Intech Investment Management LLC
Intech Investment Management LLC increased its holdings in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 39.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,578 shares of the company’s stock after purchasing an additional 3,294 shares during the quarter. Intech Investment […] - 2025-03-26 06:23:12
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have earned an average rating of “Buy” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokerages that have issued ratings on the stock in […] - 2025-03-13 04:20:58
Rhumbline Advisers Reduces Stake in Castle Biosciences, Inc. (NASDAQ:CSTL)
Rhumbline Advisers reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,892 shares of the company’s stock after selling 1,009 shares during the quarter. Rhumbline Advisers’ holdings in […] - 2025-03-06 07:53:36
Castle Biosciences, Inc. (NASDAQ:CSTL) Receives $40.29 Consensus Target Price from Brokerages
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are presently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have covered the stock […] - 2025-02-21 05:11:00
R Squared Ltd Acquires Shares of 1,590 Castle Biosciences, Inc. (NASDAQ:CSTL)
R Squared Ltd acquired a new stake in shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,590 shares of the company’s stock, valued at approximately $42,000. Other institutional investors and […] - 2025-02-03 06:49:05

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CSTL holdings

DateNumber of CSTL Shares HeldBase Market Value of CSTL SharesLocal Market Value of CSTL SharesChange in CSTL Shares HeldChange in CSTL Base ValueCurrent Price per CSTL Share HeldPrevious Price per CSTL Share Held
2025-09-26 (Friday)53,314USD 1,210,761USD 1,210,761
2025-09-25 (Thursday)53,314USD 1,212,360CSTL holding increased by 3732USD 1,212,3600USD 3,732 USD 22.74 USD 22.67
2025-09-24 (Wednesday)53,314USD 1,208,628USD 1,208,628
2025-09-17 (Wednesday)52,968USD 1,155,762CSTL holding increased by 3708USD 1,155,7620USD 3,708 USD 21.82 USD 21.75
2025-09-16 (Tuesday)52,968USD 1,152,054USD 1,152,054
2025-09-12 (Friday)52,622USD 1,127,163USD 1,127,163
2025-09-11 (Thursday)52,622CSTL holding increased by 692USD 1,197,151CSTL holding decreased by -52285USD 1,197,151692USD -52,285 USD 22.75 USD 24.06
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CSTL by Blackrock for IE00B3VWM098

Show aggregate share trades of CSTL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY692 22.750* 22.70
2025-08-21SELL-120 19.970* 22.72 Profit of 2,726 on sale
2025-07-31BUY360 15.150* 22.78
2025-06-30SELL-240 20.420* 23.35 Profit of 5,603 on sale
2025-06-25SELL-120 19.470* 23.42 Profit of 2,811 on sale
2025-06-20SELL-240 18.520* 23.52 Profit of 5,645 on sale
2025-05-23BUY120 16.100* 24.53
2025-05-19SELL-120 16.400* 24.82 Profit of 2,979 on sale
2025-05-15SELL-360 16.480* 24.96 Profit of 8,987 on sale
2025-05-12SELL-120 17.040* 25.19 Profit of 3,022 on sale
2025-05-09SELL-120 16.785* 25.26 Profit of 3,031 on sale
2025-04-30SELL-120 20.050* 25.73 Profit of 3,088 on sale
2025-04-24SELL-242 20.930* 25.95 Profit of 6,280 on sale
2025-04-17SELL-121 21.510* 26.19 Profit of 3,169 on sale
2025-04-15SELL-363 21.050* 26.30 Profit of 9,546 on sale
2025-04-14SELL-363 19.890* 26.37 Profit of 9,571 on sale
2025-04-09SELL-484 20.110* 26.59 Profit of 12,871 on sale
2025-04-07SELL-847 19.090* 26.77 Profit of 22,678 on sale
2025-04-04SELL-1,210 18.570* 26.87 Profit of 32,514 on sale
2025-03-31BUY121 20.020* 27.12
2025-03-19SELL-242 20.540* 27.85 Profit of 6,740 on sale
2025-03-14SELL-726 19.290* 28.19 Profit of 20,462 on sale
2025-03-13SELL-242 18.760* 28.32 Profit of 6,853 on sale
2025-03-12SELL-4,114 19.630* 28.45 Profit of 117,025 on sale
2025-03-07SELL-242 20.210* 28.85 Profit of 6,982 on sale
2025-03-06SELL-363 20.590* 28.98 Profit of 10,519 on sale
2025-03-03SELL-121 21.270* 29.33 Profit of 3,549 on sale
2025-02-28SELL-5,447 21.680* 29.46 Profit of 160,461 on sale
2025-02-26SELL-133 26.040* 29.59 Profit of 3,935 on sale
2025-02-25SELL-399 25.090* 29.67 Profit of 11,836 on sale
2025-02-18BUY665 26.720* 29.99
2025-02-13BUY133 27.610* 30.14
2025-02-12BUY133 27.850* 30.19
2025-02-11BUY399 28.120* 30.23
2025-02-06BUY1,197 27.830* 30.40
2025-01-27BUY133 26.650* 30.95
2024-12-30BUY665 26.660* 31.45
2024-12-06BUY532 31.190* 31.53
2024-12-05BUY133 32.160* 31.51
2024-12-04BUY665 31.880* 31.50
2024-11-29BUY665 30.280* 31.58
2024-11-27BUY532 30.440* 31.68
2024-11-26BUY133 30.570* 31.73
2024-11-21BUY665 28.880* 32.10
2024-11-20BUY399 28.450* 32.30
2024-11-18BUY1,596 27.900* 32.79
2024-11-12BUY1,064 32.780* 32.79
2024-11-08BUY665 33.290* 32.75
2024-11-07BUY1,995 33.310* 32.71
2024-11-06BUY264 32.660* 32.71
2024-10-31BUY132 34.670* 32.49
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CSTL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19118,6580203,89058.2%
2025-09-1886,6930206,73941.9%
2025-09-1727,039677,52134.9%
2025-09-1649,9730213,49023.4%
2025-09-1539,2460306,41512.8%
2025-09-1235,3912588,19340.1%
2025-09-1138,0300102,19337.2%
2025-09-1053,5220150,49135.6%
2025-09-0962,336193,44466.7%
2025-09-0855,93210194,95658.9%
2025-09-0543,845067,69664.8%
2025-09-0454,0739,081123,43743.8%
2025-09-03118,250292218,15554.2%
2025-09-02172,9384,866229,11675.5%
2025-08-29123,5080164,41775.1%
2025-08-28172,3590231,07574.6%
2025-08-27246,6817,090407,34260.6%
2025-08-26122,9080161,30276.2%
2025-08-2566,0640106,76961.9%
2025-08-2285,9630114,43275.1%
2025-08-2137,391056,08766.7%
2025-08-2055,0091793,76358.7%
2025-08-1932,6240103,24031.6%
2025-08-1834,96860085,74440.8%
2025-08-1569,817403151,95745.9%
2025-08-1473,1270199,06136.7%
2025-08-13645,5336251,181,13054.7%
2025-08-12120,9060187,67664.4%
2025-08-1156,0510132,77142.2%
2025-08-0862,7000231,88727.0%
2025-08-07121,02124333,24936.3%
2025-08-06164,0784488,86233.6%
2025-08-05238,600915767,44731.1%
2025-08-0488,1000384,56222.9%
2025-08-0166,0300114,01257.9%
2025-07-3183,71111144,23758.0%
2025-07-3043,5500132,03233.0%
2025-07-2942,809079,02754.2%
2025-07-2832,280814104,20431.0%
2025-07-2533,072082,33140.2%
2025-07-2450,2490111,61245.0%
2025-07-2358,5790129,45945.2%
2025-07-2259,718404155,28138.5%
2025-07-2192,01329192,03947.9%
2025-07-1882,4900165,41549.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.